Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is
typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic …

The management of primary CNS lymphoma is one of the most controversial topics in neuro-
oncology because of the complexity of the disease and the very few controlled studies …

The management of primary central nervous system (PCNSL) is one of the most
controversial topics in neuro-oncology because of the complexity of the disease and the …

High-dose methotrexate-based chemotherapy is the mainstay of treatment of primary central
nervous system lymphoma (PCNSL), but relapses remain frequent. High-dose …

Purpose A multicenter phase II study was conducted to assess the efficacy of rituximab,
methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced …

Background High-dose methotrexate is the standard of care for patients with newly
diagnosed primary CNS lymphoma. The role of whole brain radiotherapy is controversial …

Background Chemotherapy with high-dose methotrexate is the conventional approach to
treat primary CNS lymphomas, but superiority of polychemotherapy compared with high …

Standardized guidelines for the baseline evaluation and response assessment of primary
CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly …

Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …

Purpose The purpose of this study was to analyze prognostic factors for patients with newly
diagnosed primary CNS lymphoma (PCNSL) in order to establish a predictive model that …